BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 28208810)

  • 1. Shp2 Plays a Critical Role in IL-6-Induced EMT in Breast Cancer Cells.
    Sun X; Zhang J; Wang Z; Ji W; Tian R; Zhang F; Niu R
    Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28208810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SHP2 positively regulates TGFβ1-induced epithelial-mesenchymal transition modulated by its novel interacting protein Hook1.
    Li S; Wang L; Zhao Q; Liu Y; He L; Xu Q; Sun X; Teng L; Cheng H; Ke Y
    J Biol Chem; 2014 Dec; 289(49):34152-60. PubMed ID: 25331952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Src-homology 2 domain-containing tyrosine phosphatase 2 promotes oral cancer invasion and metastasis.
    Wang HC; Chiang WF; Huang HH; Shen YY; Chiang HC
    BMC Cancer; 2014 Jun; 14():442. PubMed ID: 24931737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A tyrosine phosphatase SHP2 gain-of-function mutation enhances malignancy of breast carcinoma.
    Hu Z; Wang X; Fang H; Liu Y; Chen D; Zhang Q; Liu X; Wei D; Qu C; Wang S
    Oncotarget; 2016 Feb; 7(5):5664-76. PubMed ID: 26673822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Notch1 signaling regulates the epithelial-mesenchymal transition and invasion of breast cancer in a Slug-dependent manner.
    Shao S; Zhao X; Zhang X; Luo M; Zuo X; Huang S; Wang Y; Gu S; Zhao X
    Mol Cancer; 2015 Feb; 14(1):28. PubMed ID: 25645291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interplay between YB-1 and IL-6 promotes the metastatic phenotype in breast cancer cells.
    Castellana B; Aasen T; Moreno-Bueno G; Dunn SE; Ramón y Cajal S
    Oncotarget; 2015 Nov; 6(35):38239-56. PubMed ID: 26512918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shp2 promotes metastasis of prostate cancer by attenuating the PAR3/PAR6/aPKC polarity protein complex and enhancing epithelial-to-mesenchymal transition.
    Zhang K; Zhao H; Ji Z; Zhang C; Zhou P; Wang L; Chen Q; Wang J; Zhang P; Chen Z; Zhu HH; Gao WQ
    Oncogene; 2016 Mar; 35(10):1271-82. PubMed ID: 26050620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EGF augments TGFβ-induced epithelial-mesenchymal transition by promoting SHP2 binding to GAB1.
    Buonato JM; Lan IS; Lazzara MJ
    J Cell Sci; 2015 Nov; 128(21):3898-909. PubMed ID: 26359300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of CXCR4-mediated chemotaxis and chemoinvasion of breast cancer cells.
    Fernandis AZ; Prasad A; Band H; Klösel R; Ganju RK
    Oncogene; 2004 Jan; 23(1):157-67. PubMed ID: 14712221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NTN4 is associated with breast cancer metastasis via regulation of EMT-related biomarkers.
    Xu X; Yan Q; Wang Y; Dong X
    Oncol Rep; 2017 Jan; 37(1):449-457. PubMed ID: 27840993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PTP1B promotes aggressiveness of breast cancer cells by regulating PTEN but not EMT.
    Liu X; Chen Q; Hu XG; Zhang XC; Fu TW; Liu Q; Liang Y; Zhao XL; Zhang X; Ping YF; Bian XW
    Tumour Biol; 2016 Oct; 37(10):13479-13487. PubMed ID: 27465552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin 6 inhibits proliferation and, in cooperation with an epidermal growth factor receptor autocrine loop, increases migration of T47D breast cancer cells.
    Badache A; Hynes NE
    Cancer Res; 2001 Jan; 61(1):383-91. PubMed ID: 11196191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of SHP2 tyrosine phosphatase promotes the tumorigenesis of breast carcinoma.
    Hu Z; Fang H; Wang X; Chen D; Chen Z; Wang S
    Oncol Rep; 2014 Jul; 32(1):205-12. PubMed ID: 24858400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-6-induced epithelial-mesenchymal transition through signal transducer and activator of transcription 3 in human cervical carcinoma.
    Miao JW; Liu LJ; Huang J
    Int J Oncol; 2014 Jul; 45(1):165-76. PubMed ID: 24806843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fucoidan induces changes in the epithelial to mesenchymal transition and decreases metastasis by enhancing ubiquitin-dependent TGFβ receptor degradation in breast cancer.
    Hsu HY; Lin TY; Hwang PA; Tseng LM; Chen RH; Tsao SM; Hsu J
    Carcinogenesis; 2013 Apr; 34(4):874-84. PubMed ID: 23275155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. JAK/STAT3 signaling is required for TGF-β-induced epithelial-mesenchymal transition in lung cancer cells.
    Liu RY; Zeng Y; Lei Z; Wang L; Yang H; Liu Z; Zhao J; Zhang HT
    Int J Oncol; 2014 May; 44(5):1643-51. PubMed ID: 24573038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein tyrosine phosphatase Shp2 deficiency in podocytes attenuates lipopolysaccharide-induced proteinuria.
    Hsu MF; Bettaieb A; Ito Y; Graham J; Havel PJ; Haj FG
    Sci Rep; 2017 Mar; 7(1):461. PubMed ID: 28352079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of SHP2 in basal-like and triple-negative breast cells induces basal-to-luminal transition, hormone dependency, and sensitivity to anti-hormone treatment.
    Zhao H; Agazie YM
    BMC Cancer; 2015 Mar; 15():109. PubMed ID: 25885600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The gain-of-function mutation E76K in SHP2 promotes CAC tumorigenesis and induces EMT via the Wnt/β-catenin signaling pathway.
    Zhang Q; Li Y; Zhao R; Wang X; Fan C; Xu Y; Liu Y; Li J; Wang S
    Mol Carcinog; 2018 May; 57(5):619-628. PubMed ID: 29323748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upregulation of MEK5 by Stat3 promotes breast cancer cell invasion and metastasis.
    Liu F; Zhang H; Song H
    Oncol Rep; 2017 Jan; 37(1):83-90. PubMed ID: 27878304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.